Quick Answer
Esperion Therapeutics, Inc. reported Total Assets of $465.89 million for fiscal year 2025.
Esperion Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $465.89M | +35.5% |
| 2024 | $343.82M | +67.1% |
| 2023 | $205.80M | -17.0% |
| 2022 | $247.94M | -35.0% |
| 2021 | $381.59M | +8.0% |
| 2020 | $353.26M | +64.7% |
| 2019 | $214.45M | +49.5% |
| 2018 | $143.45M | -48.4% |
| 2017 | $277.83M | +13.3% |
| 2016 | $245.21M | -17.0% |
| 2015 | $295.57M | +106.3% |
| 2014 | $143.28M | +83.0% |
| 2013 | $78.29M | +970.7% |
| 2012 | $7.31M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $364.02M | +15.9% | +4.9% |
| June 30, 2025 | $347.08M | -1.5% | +7.1% |
| March 31, 2025 | $324.03M | -13.1% | -5.8% |
| December 31, 2024 | $343.82M | +67.1% | +9.5% |
| September 30, 2024 | $314.11M | +41.9% | -10.8% |
| June 30, 2024 | $352.32M | +50.2% | -5.6% |
| March 31, 2024 | $373.06M | +48.1% | +81.3% |
| December 31, 2023 | $205.80M | -17.0% | -7.0% |
- Esperion Therapeutics, Inc. showed an increase of +35.5% in Total Assets compared to the prior fiscal year.
- Over the 2012–2025 period, Esperion Therapeutics, Inc.’s total assets has grown by 6271.1% (from $7.31 million to $465.89 million).
- The most recent figure is from Esperion Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: